Stocks-RMD-ResMed Inc

RMD ResMed Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

FINANCIAL SUMMARY

For the fiscal year ended 30/6/2023: ResMed Inc's revenues increased by 18.02% and amounted to 4.22B. Net income increased by 15.15% to 897.56M. Net assets increased by 22.89% to 4.13B and EPS increased from 5.30 to 6.09.
RMD's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
54.03%
Net Profit Margin
18.89%
Operating Margin
26.98%
Return On Investment
15.17%